ACRS•benzinga•
Jefferies Upgrades Aclaris Therapeutics to Buy, Raises Price Target to $7
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2024 by benzinga